Primary Renal Lymphoma: Report of 32 Cases—A Retrospective Multicenter PLRG Analysis
Authors:
- Magdalena WitkowskaMWMagdalena Witkowska
- Joanna Romejko-JarosińskaJRJoanna Romejko-Jarosińska
- Agnieszka GizaAGAgnieszka Giza
- Joanna Drozd-SokołowskaJDJoanna Drozd-Sokołowska
- Damian MikulskiDMDamian Mikulski
- Janusz HałkaJHJanusz Hałka
- Anna Morawska-KrekoraAMAnna Morawska-Krekora
- Ewa Paszkiewicz-KozikEPEwa Paszkiewicz-Kozik
- Kamil WdowiakKWKamil Wdowiak
- Dariusz WołowiecDWDariusz Wołowiec
- on behalf of the Polish Lymphoma Research GroupOGon behalf of the Polish Lymphoma Research Group
Open Access
- 21 February 2025
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 13 (3) , 548
Abstract
Introduction: Primary renal lymphoma is extremely rare, accounting for less than 1% of all lymphomas. Objectives: The aim of this study was to describe a group of patients with primary renal lymphoma diagnosed in hematology and oncology centers aligned with the Polish Lymphoma Research Group (PLRG). Patients and methods: This was a retrospective analysis of adult patients with primary renal lymphoma diagnosed at PLRG centers. Results: Thirty-two patients were diagnosed in seven centers over 24 years (2000–2023). The most common type of lymphoma was diffuse large B-cell lymphoma (DLBCL). The median progression-free survival (PFS) after first-line treatment was 2.1 (95% CI: 1.07–4.18) years, while the median overall survival (OS) was 6.3 (95% CI: 1.82–6.34) years. The median age at diagnosis was 63.3 years old, and 59.4% of the patients were females. In multivariate Cox regression for PFS, only creatinine > 1.5 mg/dL (HR 10.2, 95% CI: 2.08–50.09, p = 0.004) and hemoglobin (Hgb) < 10 g/dL (HR 8.39, 95% CI: 1.88–37.49) were associated with inferior PFS. Patients who achieved complete remission (CR) after first-line of treatment had significantly longer PFS (median 4.18, 95% CI: 2.02–4.18 vs. median 0.73, 95% CI: 0.50–0.79, p = 0.004) and OS (median not reached vs. median 1.49, 95% CI: 0.43–6.33, p = 0.001). Patients treated with nephrectomy had longer OS (median not reached vs. median 5.07, 95% CI: 1.32–5.08, p = 0.05). However, in multivariate Cox regression for OS, only hypoalbuminemia was an independent factor for inferior survival (HR 5.44, 95% CI: 1.12–26.38, p = 0.04). Conclusions: Primary renal lymphoma is an extremely rare type of lymphoma with a poor prognosis. The prognosis may improve with future advances in treatment, including nephrectomy.Keywords
This publication has 27 references indexed in Scilit:
- Primary renal lymphoma: a comprehensive review of the pathophysiology, clinical presentation, imaging features, management and prognosisBMJ Case Reports, 2020
- Lymphomas with kidney involvement: the French multicenter retrospective LyKID studyLeukemia & Lymphoma, 2020
- Primary renal lymphoma: A population‐based analysis using the SEER program (1973‐2015)European Journal of Haematology, 2019
- Primary renal large B‐cell lymphoma imitating invasive renal cell carcinoma with inferior vena cava tumor thrombusUrology Case Reports, 2018
- Patrones imagenológicos por TCMD del linfoma renalRevista Argentina de Radiología / Argentinian Journal of Radiology, 2015
- Lymphomas and lymphoproliferative disorders clinically presenting as renal carcinoma: A clinicopathological study of 14 casesPathology, 2013
- Membranoproliferative glomerulonephritis, mantle cell lymphoma infiltration, and acute kidney injuryInternational Urology and Nephrology, 2012
- Acute kidney injury secondary to renal large B-cell lymphoma: role of early renal biopsyInternational Urology and Nephrology, 2010
- Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapyAnnals of Oncology, 2009
- PRIMARY RENAL LYMPHOMA: A RARE NEOPLASM THAT MAY PRESENT AS A PRIMARY RENAL MASSJournal of Urology, 2005